InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Humer Franz B, Director. Director active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 3 filings have been logged. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
044,178 shares0
Common Stock
SEC:0001214659-22-008172:0·
016,498 shares0
Common Stock
SEC:0001214659-21-006499·
016,498 shares0
Common Stock
SEC:0001214659-21-006499:0·
3 of 3 declarations
About Humer Franz B
Franz B. Humer is a Board Member at Allogene Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. Humer brings valuable expertise in the biopharmaceutical sector, which is essential for the company's development.
